SG11202113242QA - Isolation of fetal cells using facs - Google Patents

Isolation of fetal cells using facs

Info

Publication number
SG11202113242QA
SG11202113242QA SG11202113242QA SG11202113242QA SG11202113242QA SG 11202113242Q A SG11202113242Q A SG 11202113242QA SG 11202113242Q A SG11202113242Q A SG 11202113242QA SG 11202113242Q A SG11202113242Q A SG 11202113242QA SG 11202113242Q A SG11202113242Q A SG 11202113242QA
Authority
SG
Singapore
Prior art keywords
facs
isolation
fetal cells
fetal
cells
Prior art date
Application number
SG11202113242QA
Other languages
English (en)
Inventor
Bolette Nicolaisen
David Kølvraa
Inga Christensen
Katarina Ravn
Line Jeppesen
Lotte Hatt
Palle Jensen
Ripudaman Singh
Original Assignee
Arcedi Biotech Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arcedi Biotech Aps filed Critical Arcedi Biotech Aps
Publication of SG11202113242QA publication Critical patent/SG11202113242QA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Physiology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Developmental Biology & Embryology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
SG11202113242QA 2019-06-07 2020-06-08 Isolation of fetal cells using facs SG11202113242QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19179087 2019-06-07
PCT/EP2020/065832 WO2020245459A1 (en) 2019-06-07 2020-06-08 Isolation of fetal cells using facs

Publications (1)

Publication Number Publication Date
SG11202113242QA true SG11202113242QA (en) 2021-12-30

Family

ID=66793879

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202113242QA SG11202113242QA (en) 2019-06-07 2020-06-08 Isolation of fetal cells using facs

Country Status (16)

Country Link
US (2) US11573229B2 (ru)
EP (2) EP3980773B1 (ru)
JP (1) JP2022536121A (ru)
KR (1) KR20220047929A (ru)
CN (1) CN114041053A (ru)
AU (1) AU2020289708A1 (ru)
BR (1) BR112021024474A2 (ru)
CA (1) CA3142663A1 (ru)
EA (1) EA202193200A1 (ru)
ES (1) ES2955791T3 (ru)
IL (2) IL288621B2 (ru)
MX (1) MX2021015044A (ru)
PL (1) PL3980773T3 (ru)
SG (1) SG11202113242QA (ru)
WO (1) WO2020245459A1 (ru)
ZA (1) ZA202110215B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113087793B (zh) * 2021-05-12 2022-04-12 福州迈新生物技术开发有限公司 抗ck14蛋白单克隆抗体及其细胞株、制备方法和应用
CN112980779B (zh) * 2021-05-20 2021-08-24 广州凯普医药科技有限公司 一种从孕妇宫颈脱落细胞中分离胎盘滋养层细胞的方法
WO2023104773A1 (en) * 2021-12-06 2023-06-15 Arcedi Biotech Aps Isolation and diagnostics of fetal cells

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641628A (en) 1989-11-13 1997-06-24 Children's Medical Center Corporation Non-invasive method for isolation and detection of fetal DNA
US5629147A (en) 1992-07-17 1997-05-13 Aprogenex, Inc. Enriching and identifying fetal cells in maternal blood for in situ hybridization
EP0691901A1 (fr) 1993-04-02 1996-01-17 Compagnie Geofinanciere Sa Installation et procede de decoupage par jet de fluide cryogenique
AU7474394A (en) 1993-07-19 1995-02-20 Aprogenex, Inc. Enriching and identifying fetal cells in maternal blood for in situ hybridization
US5714325A (en) 1993-09-24 1998-02-03 New England Medical Center Hospitals Prenatal diagnosis by isolation of fetal granulocytes from maternal blood
US5648222A (en) 1994-07-27 1997-07-15 The Trustees Of Columbia University In The City Of New York Method for preserving cells, and uses of said method
GB9603249D0 (en) 1996-02-16 1996-04-17 Univ Nottingham Foetal cell analysis
GB0009179D0 (en) 2000-04-13 2000-05-31 Imp College Innovations Ltd Non-invasive prenatal diagnosis
CA2409703A1 (en) 2000-05-16 2001-11-22 Shin-Ichi Nishikawa Novel differentiation inducing process of embryonic stem cell to ectodermal cell and its use
JP2004519247A (ja) 2001-03-20 2004-07-02 オーソ・クリニカル・ダイアグノスティックス・インコーポレーテッド 発現プロファイルおよび使用法
US20030036100A1 (en) 2001-04-10 2003-02-20 Imperial College Innovations Ltd. Simultaneous determination of phenotype and genotype
FR2824144B1 (fr) 2001-04-30 2004-09-17 Metagenex S A R L Methode de diagnostic prenatal sur cellule foetale isolee du sang maternel
JP2006502092A (ja) 2002-03-08 2006-01-19 プロテイン デザイン ラブス インコーポレイティド ガン抗原ｔｍｅｆｆ２に対する抗体及びそれらの使用
US20040197832A1 (en) 2003-04-03 2004-10-07 Mor Research Applications Ltd. Non-invasive prenatal genetic diagnosis using transcervical cells
US20050181429A1 (en) 2003-04-03 2005-08-18 Monaliza Medical Ltd. Non-invasive prenatal genetic diagnosis using transcervical cells
US7718367B2 (en) 2005-03-18 2010-05-18 The Chinese University Of Hong Kong Markers for prenatal diagnosis and monitoring
CA2651367A1 (en) 2005-05-11 2006-11-16 Genetic Technologies Limited Methods of enriching fetal cells
DK2287619T3 (da) 2005-12-08 2013-07-29 Univ Aarhus Detektion af føtale celler fra moderens blod
GB0616045D0 (en) 2006-08-11 2006-09-20 Univ Bristol Blood cell separation
WO2008132753A2 (en) 2007-05-01 2008-11-06 Tel Hashomer Medical Research Infrastructure And Services Ltd. Methods and kits for detecting fetal cells in the maternal blood
EP2250497B1 (en) 2008-02-18 2014-09-10 Genetic Technologies Limited Cell processing and/or enrichment methods
PL2385992T3 (pl) 2009-01-07 2015-06-30 Arcedi Biotech Aps Wzbogacanie i identyfikacja komórek płodu we krwi matki oraz ligandy do takiego zastosowania
NZ595982A (en) 2009-04-22 2013-10-25 Clinical Genomics Pty Ltd Method and apparatus for isolating a target bioentity from a biological sample
SG10201509230VA (en) * 2010-11-09 2015-12-30 Arcedi Biotech Aps Enrichment And Identification Of Fetal Cells In Maternal Blood And Ligands For Such Use

Also Published As

Publication number Publication date
EP4242652A3 (en) 2023-12-06
IL288621A (en) 2022-02-01
EP3980773B1 (en) 2023-07-12
JP2022536121A (ja) 2022-08-12
IL288621B2 (en) 2024-05-01
PL3980773T3 (pl) 2023-11-27
EP3980773C0 (en) 2023-07-12
MX2021015044A (es) 2022-04-06
EP3980773A1 (en) 2022-04-13
IL308999A (en) 2024-01-01
ZA202110215B (en) 2023-06-28
EP4242652A2 (en) 2023-09-13
AU2020289708A1 (en) 2022-01-20
IL288621B1 (en) 2024-01-01
CN114041053A (zh) 2022-02-11
US20230130312A1 (en) 2023-04-27
KR20220047929A (ko) 2022-04-19
CA3142663A1 (en) 2020-12-10
US20210199664A1 (en) 2021-07-01
WO2020245459A1 (en) 2020-12-10
BR112021024474A2 (pt) 2022-01-18
US11573229B2 (en) 2023-02-07
EA202193200A1 (ru) 2022-03-17
ES2955791T3 (es) 2023-12-07

Similar Documents

Publication Publication Date Title
ZA202110215B (en) Isolation of fetal cells using facs
IL287553A (en) Modified pluripotent cells
IL276131A (en) Methods for using car t cells
IL286218A (en) Solid state forms of ripretinib
IL285422A (en) Transposon-based modifications of immune cells
GB201904612D0 (en) Reaction of glycoladehyde
EP3449018A4 (en) REAL-TIME PCR WITH MULTIPLEXED OPTIMIZED MISMATCH AMPLIFICATION (MOMA) FOR THE EVALUATION OF FETAL WELL-BEING
EP3941631A4 (en) ISOLATION OF SINGLE CELLS AND THEIR USES
ZA202105808B (en) Secure storage isolation
SI3749673T1 (sl) Kristalinična oblika biktegravir natrija
GB2605934B (en) In vitro propagation of primary cancer cells
HUE061671T2 (hu) Akkumulátorcella
EP3870152A4 (en) FUSOGENIC LIPOSOMES FOR SELECTIVE IMAGING OF TUMOR CELLS
IL288301A (en) Methods for the culture of pluripotent stem cells
EP3755213C0 (en) USES OF FETAL TISSUE EXTRACT
CA211336S (en) Set of sofa modules
ZA202006925B (en) Hopper coupler
GB201917499D0 (en) Methods of synthesis
ZA202107052B (en) Phase-correction of radiofrequency-multiplexed signals
EP3801573A4 (en) METHODS OF ACTIVATING CELLS VIA PTP-1B INHIBITION
AU2018900373A0 (en) Pre-natal cell isolation
AU2019904589A0 (en) Methods of activating cells
EP3983423A4 (en) SYNTHESIS OF 3-AZIDO-3-DESOXY-D-GALACTOPYRANOSE
GB201908444D0 (en) Synthesis of diphosphate derivatives
GB201902000D0 (en) Synchronisation signals